Group 1 - This week, one new stock, Aifenda, will be available for subscription on the ChiNext board, with subscription starting on Monday [2][3] - Last week, a new member, Balanshi, debuted on the Beijing Stock Exchange, experiencing a significant first-day increase of 205.13% [3][4] - Aifenda's total issuance is 2,167,000 shares, with an online issuance of 520,050 shares and a maximum subscription limit of 50,000 shares [3] Group 2 - This week, two companies are undergoing IPO reviews: Xihua Technology on the Shanghai Main Board and China Uranium Industry on the Shenzhen Main Board [5] - China Uranium Industry plans to raise 4.11 billion yuan through its IPO, focusing on the comprehensive utilization of natural uranium and radioactive associated mineral resources [5][9] - The projected revenues for China Uranium Industry from 2022 to 2024 are 10.535 billion yuan, 14.801 billion yuan, and 17.279 billion yuan, respectively, with net profits of 1.334 billion yuan, 1.262 billion yuan, and 1.458 billion yuan [5][6] Group 3 - China Uranium Industry's total assets are projected to reach 20.682 billion yuan by the end of 2024, with a debt-to-asset ratio of 42.53% [6] - The company is involved in several projects, including the in-situ leaching uranium mining project in Inner Mongolia, with a total investment of 1.583 billion yuan [7][8] - The actual controller, China National Nuclear Corporation, indirectly holds 79.48% of the shares in China Uranium Industry, highlighting its significant role in the domestic nuclear fuel cycle industry [9]
IPO研究丨本周2家上会，核产业“国家队”待审